Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi

Journal of Infectious Diseases

Volumn 203, Issue 4, 2011, Pages 464-472

  Kapito Tembo, Atupele ^a,b   Meshnick, Steven R ^a   Van Hensbroek, Michaël Boele ^e,f   Phiri, Kamija ^c   Fitzgerald, Margaret ^d   Mwapasa, Victor ^c  

^a IL   (United States)

^b MINISTRY OF HEALTH   (Malawi)

^c UNIVERSITY OF MALAWI   (Malawi)

^d MÉDECINS SANS FRONTIÈRES   (Switzerland)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; HEMOGLOBIN; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; PYRIMETHAMINE PLUS SULFADOXINE; ZIDOVUDINE;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFICACY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALAWI; PARASITEMIA; PLASMODIUM MALARIAE INFECTION; PLASMODIUM OVALE MALARIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; ANEMIA; ANTIMALARIALS; CHEMOPREVENTION; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; FEMALE; HIV INFECTIONS; HUMANS; MALARIA; MALAWI; MIDDLE AGED; PARASITEMIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 79751499134     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq072     Document Type: Article

References (48)

1. Desai M, ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007; 7:93-104.
2. Perrault SD, Hajek J, Zhong K, et al.Human immunodeficiency virus coinfection increases placental parasite density and transplacental malaria transmission in Western Kenya. Am J Trop Med Hyg 2009; 80:119-25.
3. Verhoeff FH, Brabin BJ, Hart CA, Chimsuku L, Kazembe P, Broadhead RL. Increased prevalence of malaria inHIV-infected pregnant women and its implications for malaria control. Trop Med Int Health 1999; 4:5-12. (Pubitemid 29081212)
4. van Eijk AM, Ayisi JG, ter Kuile FO, et al. HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya. AIDS 2003; 17:595-603.
5. ter Kuile FO, Parise ME, Verhoeff FH, et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 2004; 71:41-54.
6. World Health Organization. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults: Recommendations for a public health approach. Geneva, Switzerland: World health Organization; 2006.
7. World Health Organization. Guidelines for the treatment of malaria. 1st ed., Geneva, Switzerland: World health Organization; 2006.
8. Newman PM, Wanzira H, Tumwine G, et al. Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda. Malar J 2009; 8:254.
9. Meshnick SR, Mwapasa V, Rogerson SJ. Protecting pregnant women from malaria in areas of high HIV infection prevalence. J Infect Dis 2006; 194:273-5. (Pubitemid 44116967)
10. Briand V, Badaut C, Cot M. Placental malaria, maternal HIV infection and infant morbidity. Ann Trop Paediatr 2009; 29:71-83.
11. Hamel MJ, Greene C, Chiller T, et al. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? Am J Trop Med Hyg 2008; 79:320-30.
12. Kamya MR, Gasasira AF, Achan J, et al. Effects of trimethoprim- sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children. AIDS 2007; 21:2059-66. (Pubitemid 47462155)
13. Mermin J, Ekwaru JP, Liechty CA, et al. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: A prospective cohort study. Lancet 2006; 367:1256-61.
14. Thera MA, Sehdev PS, Coulibaly D, et al. Impact of trimethoprim- sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis 2005; 192:1823-9. (Pubitemid 41587836)
15. World Health Organization. Malaria and HIV interactions and their implications for public health policy. Geneva, Switzerland: World Health Organization; 2005.
16. Government of Malawi Ministry of Health. Treatment of AIDS: Guidelines for the use of antiretroviral therapy in Malawi. 2nd ed. Lilongwe, Malawi: Malawi Ministry of Health; 2006.
17. Government of Malawi Ministry of Health. National guidelines for the diagnosis, treatment and prevention of malaria in Malawi. Lilongwe, Malawi: Malawi Ministry of Health; 2007.
18. rd ed. London, UK: Edward Arnold, 1993; 78-98.
19. Taylor SM, Juliano JJ, Trottman PA, et al. High-throughput pooling and real-time PCR-based strategy for malaria detection. J Clin Microbiol 2010; 48:512-9.
20. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology 1999; 10:37-48. (Pubitemid 29014427)
21. Hernán MA, Hernández-D?́az S, Werler MM, Mitchell AA. Causal knowledge as a prerequisite for confounding evaluation: An application to birth defects epidemiology. Am J Epidemiol 2002; 155:176-84. (Pubitemid 34072741)
22. Gwatkin DR, Rutstein S, Johnson K, Suliman E, Wagstaff A, Amouzou A. Socio-economic differences in health, nutrition, and population: Malawi 1992, 2000. Washington, DC: World Bank; 2000. Report No.: 39450.
23. Vyas S, Kumaranayake L. Constructing socio-economic status indices: How to use principal components analysis. Health Policy Plan 2006; 21:459-68. (Pubitemid 44627319)
24. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: An empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003; 3:21.
25. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005; 162: 199-200. (Pubitemid 41373523)
26. Petersen MR, Deddens JA. A comparison of two methods for estimating prevalence ratios. BMC Med Res Methodol 2008; 8:9.
27. Coutinho LM, Scazufca M, Menezes PR. Methods for estimating prevalence ratios in cross-sectional studies. Rev Saude Publica 2008; 42:992-8.
28. Bello GA, Chipeta J, Aberle-Grasse J. Assessment of trends in biological and behavioural surveillance data: Is there any evidence of declining HIV prevalence or incidence in Malawi? Sex Transm Infect 2006; 82:i9-13.
29. Filler SJ, Kazembe P, Thigpen M, et al. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis 2006; 194:286-93. (Pubitemid 44116969)
30. Parise ME, Ayisi JG, Nahlen BL, et al. Efficacy of sulfadoxine- pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998; 59:813-22. (Pubitemid 28524544)
31. Hamer DH, Mwanakasale V, Macleod WB, et al. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. J Infect Dis 2007; 196:1585-94. (Pubitemid 351411955)
32. Gill CJ, Macleod WB, Mwanakasale V, et al. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. J Infect Dis 2007; 196:1577-84. (Pubitemid 351411954)
33. Bwijo B, Kaneko A, Takechi M, et al. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. Acta Trop 2003; 85:363-73. (Pubitemid 36355874)
34. Green MD, van Eijk AM, ter Kuile FO, et al. Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya. J Infect Dis 2007; 196:1403-8. (Pubitemid 351412014)
35. ter Kuile FO, van Eijk AM, Filler SJ. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: A systematic review. JAMA 2007; 297:2603-16.
36. Petersen E. In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination. Trans R Soc Trop Med Hyg 1987; 81:238-41.
37. Iyer JK, Milhous WK, Cortese JF, Kublin JG, Plowe CV. Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 2001; 358:1066-7. (Pubitemid 32925132)
38. Martin DC, Arnold JD. Treatment of acute falciparum malaria with sulfalene and trimethoprim. JAMA 1968; 203:476-80.
39. Peters PJ, Thigpen MC, Parise ME, Newman RD. Safety and toxicity of sulfadoxine/pyrimethamine: Iimplications for malaria prevention in pregnancy using intermittent preventive treatment. Drug Saf 2007; 30:481-501. (Pubitemid 46873074)
40. Siega-Riz AM, Savitz DA, Zeisel SH, Thorp JM, Herring A. Second trimester folate status and preterm birth. Am J Obstet Gynecol 2004; 191:1851-7. (Pubitemid 39601487)
41. Molloy AM, Kirke PN, Brody LC, Scott JM, Mills JL. Effects of folate and vitamin B12 deficiencies during pregnancy on fetal, infant, and child development. Food Nutr Bull 2008; 29:S101-15.
42. Folate and vitamin B12 deficiencies: Pproceedings of a WHO technical consultation held 18-21 October, 2005, in Geneva, Switzerland. Introduction. Food Nutr Bull 2008; 29:S3-4.
43. Heimpel H, Raghavachar A. Hematological side effects of co-trimoxazole. Infection 1987; 15:S248-53.
44. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343:1608-14. (Pubitemid 32162984)
45. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 2001; 153:961-8. (Pubitemid 32423782)
46. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. The teratogenic risk of trimethoprim-sulfonamides: A population based case-control study. Reprod Toxicol 2001; 15:637-46. (Pubitemid 34000933)
47. Walter J, Mwiya M, Scott N, et al. Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts. J Infect Dis 2006; 194:1510-8. (Pubitemid 44851892)
48. Nguyen-Dinh P, Steketee RW, Greenberg AE, Wirima JJ, Mulenda O, Williams SB. Rapid spontaneous postpartum clearance of Plasmodium falciparum parasitaemia in African women. Lancet 1988; 2:751-2.